DBV TECHNOLOGIE/S (DBVT) Upgraded at BidaskClub

Share on StockTwits

DBV TECHNOLOGIE/S (NASDAQ:DBVT) was upgraded by BidaskClub from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Friday, BidAskClub reports.

Several other equities research analysts also recently weighed in on DBVT. Leerink Swann reissued an “outperform” rating on shares of DBV TECHNOLOGIE/S in a report on Thursday, December 20th. Zacks Investment Research downgraded DBV TECHNOLOGIE/S from a “hold” rating to a “sell” rating in a report on Tuesday, December 11th. JMP Securities reissued a “buy” rating and issued a $20.00 price objective on shares of DBV TECHNOLOGIE/S in a report on Wednesday, March 6th. Stifel Nicolaus reissued a “hold” rating and issued a $10.00 price objective on shares of DBV TECHNOLOGIE/S in a report on Wednesday, March 6th. Finally, Jefferies Financial Group downgraded DBV TECHNOLOGIE/S from a “buy” rating to a “hold” rating and set a $5.25 price objective for the company. in a report on Thursday, December 20th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company. DBV TECHNOLOGIE/S currently has an average rating of “Hold” and a consensus price target of $16.03.

DBVT stock opened at $8.76 on Friday. The company has a market capitalization of $466.01 million, a PE ratio of -2.60 and a beta of 1.97. DBV TECHNOLOGIE/S has a twelve month low of $3.60 and a twelve month high of $25.77.

Several hedge funds have recently bought and sold shares of the company. Norges Bank purchased a new stake in shares of DBV TECHNOLOGIE/S during the fourth quarter worth approximately $321,000. Exane Asset Management raised its stake in shares of DBV TECHNOLOGIE/S by 30.0% during the third quarter. Exane Asset Management now owns 65,000 shares of the company’s stock worth $1,460,000 after purchasing an additional 15,000 shares during the last quarter. Bailard Inc. raised its stake in shares of DBV TECHNOLOGIE/S by 57.4% during the third quarter. Bailard Inc. now owns 74,000 shares of the company’s stock worth $1,662,000 after purchasing an additional 27,000 shares during the last quarter. OLD Mission Capital LLC raised its stake in shares of DBV TECHNOLOGIE/S by 1,278.6% during the fourth quarter. OLD Mission Capital LLC now owns 143,338 shares of the company’s stock worth $920,000 after purchasing an additional 132,941 shares during the last quarter. Finally, Premier Asset Management LLC purchased a new stake in shares of DBV TECHNOLOGIE/S during the fourth quarter worth approximately $1,121,000. 44.09% of the stock is owned by institutional investors and hedge funds.

DBV TECHNOLOGIE/S Company Profile

DBV Technologies SA, a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in children, adolescents, and adults.

Featured Article: Why is the LIBOR significant?

Analyst Recommendations for DBV TECHNOLOGIE/S (NASDAQ:DBVT)

Receive News & Ratings for DBV TECHNOLOGIE/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DBV TECHNOLOGIE/S and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Lions Gate Entertainment  Stock Rating Reaffirmed by Barrington Research
Lions Gate Entertainment Stock Rating Reaffirmed by Barrington Research
Ingredion  Raised to Hold at Zacks Investment Research
Ingredion Raised to Hold at Zacks Investment Research
Adviser Investments LLC Buys New Stake in Thermo Fisher Scientific Inc.
Adviser Investments LLC Buys New Stake in Thermo Fisher Scientific Inc.
Cosan Ltd  Position Boosted by Acadian Asset Management LLC
Cosan Ltd Position Boosted by Acadian Asset Management LLC
Aspen Technology, Inc.  Shares Sold by Acadian Asset Management LLC
Aspen Technology, Inc. Shares Sold by Acadian Asset Management LLC
10 15 Associates Inc. Invests $1.31 Million in VanEck Vectors Wide Moat ETF
10 15 Associates Inc. Invests $1.31 Million in VanEck Vectors Wide Moat ETF


© 2006-2019 Ticker Report